Sign in
CompletedNo phase

Mitochondrial Diseases - Long-read Genome and Transcriptome Sequencing in Cases Unresolved After Short-read Genomics

Key facts

Who runs it
University Hospital Tuebingen
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
20 people enrolled
Started
1 Mar 2019
Ended
1 Feb 2025
Type of study
Interventional
Treatments tested
  • Next Generation Sequencing (NGS)
Record updated
30 March 2025

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Unclear diagnosis Suspected genetic cause of the disease

Who cannot take part

  • Missing informed consent of the patient/ legal guardian

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The MiDiSeq project will enroll 20 unresolved index patients with suspected mitochondrial disease prioritized for genomic analysis.

The group in the trial

  • Mitochondrial diseaseOther group

    Unresolved index patients with suspected mitochondrial disease

    Treatment: Next Generation Sequencing (NGS)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
30 March 2025